Role of continuous glucose monitoring device on diabetes patient
Phase 4
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2024/02/062647
- Lead Sponsor
- Dr.Priyamadhabha Behera
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Individuals with type 2 diabetes on 3 or more oral antidiabetic agents with or without insulin HbA1C more than 7%.
Exclusion Criteria
Individuals with type 1 diabetes
Gestational diabetes mellitus
Individuals with diabetic complications (acute or chronic)
Individuals with a history of bleeding disorder
Individuals with a recent history of steroid use
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method attainment of glycemic control (HbA1c less than 7) <br/ ><br> <br/ ><br>Mean reduction in HbA1c level <br/ ><br>Timepoint: 3months <br/ ><br>6months <br/ ><br>
- Secondary Outcome Measures
Name Time Method nilTimepoint: nil